Targeted Cancer Therapeutics

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.

Learn More